ZYXI Insider Trading

Insider Ownership Percentage: 52.13%
Insider Buying (Last 12 Months): $58,240.00
Insider Selling (Last 12 Months): $432,946.49

Zynex Insider Trading History Chart

This chart shows the insider buying and selling history at Zynex by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$79ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$400k-$200k$0$200k$400kTotal Insider BuyingTotal Insider Selling

Zynex Share Price & Price History

Current Price: $8.12
Price Change: Price Increase of +0.03 (0.37%)
As of 01/6/2025 01:41 PM ET

This chart shows the closing price history over time for ZYXI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
FebMarAprMayJunJulAugSepOctNovDecJan$8.09Closing price on 01/05/25:

SEC Filings (Institutional Ownership Changes) for Zynex (NASDAQ:ZYXI)

29.68% of Zynex stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ZYXI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
202220232024$2.50Mbought$140ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4-$10M-$5M$0$5M$10MTotal InflowsTotal Outflows
Zynex logo
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Read More on Zynex

Today's Range

Now: $8.12
Low: $8.02
High: $8.15

50 Day Range

MA: $8.30
Low: $7.80
High: $9.30

52 Week Range

Now: $8.12
Low: $7.15
High: $13.77

Volume

13,074 shs

Average Volume

49,533 shs

Market Capitalization

$258.59 million

P/E Ratio

54.13

Dividend Yield

N/A

Beta

0.53

Who are the company insiders with the largest holdings of Zynex?

Zynex's top insider shareholders include:
  1. Thomas Sandgaard (CEO)
  2. Joshua R Disbrow (Director)
  3. Daniel J Moorhead (CFO)
  4. Anna Lucsok (COO)
Learn More about top insider investors at Zynex.